trending Market Intelligence /marketintelligence/en/news-insights/trending/l6qtgwxvi-unbav1kubv_g2 content esgSubNav
In This List

Proteostasis withdraws stock offering due to market conditions

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Proteostasis withdraws stock offering due to market conditions

Proteostasis Therapeutics Inc. withdrew its previously announced underwritten public offering of 9 million common shares.

The Cambridge, Mass.-based biopharma company said "current market conditions are not conducive for an offering."